Institute of Biomedical Research Corp. (MRES)
OTCMKTS · Delayed Price · Currency is USD
0.0012
-0.0003 (-20.00%)
At close: Nov 4, 2026
MRES Market Cap
MRES has a market cap or net worth of $3.3 million as of November 5, 2026. It is the 46,382nd most valuable company in the world and the 6,158th biggest in the United States. Its market cap has decreased by 84.31% in one year.
Market Cap
3.30M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#6,158 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since March 31, 2016, MRES's market cap has increased from 693.95K to 3.30M, an increase of 375.42%. That is a compound annual growth rate of 15.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 3.30M | -57.14% |
| Dec 31, 2025 | 7.70M | -83.96% |
| Dec 31, 2024 | 47.98M | 138.03% |
| Dec 29, 2023 | 20.16M | 17.54% |
| Dec 30, 2022 | 17.15M | 149.69% |
| Dec 31, 2021 | 6.87M | 971.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curative Biotechnology | 5.94M |
| OSR Health | 5.62M |
| Adaptimmune Therapeutics | 5.30M |
| Eastgate Biotech | 5.29M |
| Reviva Pharmaceuticals Holdings | 4.98M |
| Orgenesis | 4.80M |
| LianMedical | 4.20M |
| BioAtla | 3.33M |